PATENT CLAIM ANALYSIS

Application Number: 15967125
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["424", "085700"]

Abstract:
This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human inteferon like alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon, therapy, such as viral diseases and cancer.

Claim (Index 57):
A protein comprising a sequence which differs in 0 to 8 amino acids from SEQ ID NO:2, wherein said protein exhibits human interferon-like biological activities.

Metadata:
- Claim Count in Document: 173.0
- Percentile: 91.0
- Lexical Diversity: 1.62069
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12665682', '11764786', '12555762', '13841679', '14992591']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8639141331702455
- 35 USC 102 Novelty (BERT): 0.6912807792839635
- Combined Prediction Score: 0.8466507977816173
- Mean Citation Score: 730.310244
- Max Citation Score: 735.6273
- Similarity Product: 716.0835956364692

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test